The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial

Annals of Surgery

Volumn 260, Issue 6, 2014, Pages 984-992

  Koehestanie, Parviez ^a   De Jonge, Charlotte ^b,c   Berends, Frits J ^a   Janssen, Ignace M ^a   Bouvy, Nicole D ^b   Greve, Jan Willem M ^c  

^a Department of General Surgery RijnstateHospital ^*  (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Zuyderland Medical Centre   (Netherlands)

Author keywords

Bariatric surgery; Cardiovascular risk profile; Obesity; Type 2 diabetes; Weight loss

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; GLUCOSE BLOOD LEVEL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE REGULATION; BODY MASS; BODY WEIGHT; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEVICE REMOVAL; DEVICE SAFETY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DIGESTIVE IMPLANT; DUODENAL JEJUNAL BYPASS LINER; EPIGASTRIC PAIN; ESOPHAGUS PERFORATION; ESOPHAGUS TEAR; FEMALE; FOLLOW UP; GALLSTONE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMPLANT OBSTRUCTION; INSULIN BLOOD LEVEL; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MELENA; MULTICENTER STUDY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VOMITING; WEIGHT REDUCTION; ADOLESCENT; AGED; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DUODENUM; GASTROINTESTINAL ENDOSCOPY; JEJUNUM; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PROCEDURES; SURGERY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BARIATRIC SURGERY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JEJUNUM; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922274130     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000794     Document Type: Article

References (38)

1. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32: 1431-1437.
2. Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132: 2087-2102.
3. Rosemann T, Grol R, Herman K, et al. Association between obesity, quality of life, physical activity and health service utilization in primary care patients with osteoarthritis. Int J Behav Nutr Phys Act. 2008;5: 4.
4. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27: 1047-1053.
5. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial-A prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273: 219-234.
6. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357: 741-752.
7. Kral JG, Sjostrom LV, Sullivan MB. Assessment of quality of life before and after surgery for severe obesity. Am J Clin Nutr. 1992;55: 611S-614S.
8. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-Analysis. Am J Med. 2009;122: 248-256.e5.
9. Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: Analysis of 13, 871 morbidly obese patients from a national registry. Ann Surg. 2007;246: 1002-1007; discussion 1007-1009.
10. ASGE Technology Committee, Kethu SR, Banerjee S, et al. Endoluminal bariatric techniques. Gastrointest Endosc. 2012;76: 1-7.
11. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4: 55-59.
12. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11: 725-732.
13. TarnoffM, Rodriguez L, Escalona A, et al.Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23: 650-656.
14. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71: 976-982.
15. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251: 236-243.
16. de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013; 23: 1354-1360. doi: 10.1007/s11695-013-0921-3.
17. de Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther. 2012; 14: 183-189.
18. de Moura EG, Orso IR, Martins Bda C, et al. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg. 2011; 21: 941-947.
19. Escalona A, Pimentel F, SharpA, et al.Weight loss andmetabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenaljejunal bypass liner. Ann Surg. 2012;255: 1080-1085.
20. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351: 2683-2693.
21. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238: 467-484; discussion 484-485.
22. Greenway SE, Greenway FL, III, Klein S. Effects of obesity surgery on noninsulin-dependent diabetes mellitus. Arch Surg. 2002;137: 1109-1117.
23. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236: 554-559.
24. Hickey MS, Pories WJ, MacDonald KG, Jr, et al. A new paradigm for type 2 diabetes mellitus: Could it be a disease of the foregut? Ann Surg. 1998;227: 637-643; discussion 643-644.
25. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222: 339-350; discussion 350-352.
26. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244: 741-749.
27. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery [minireview]. Endocrinology. 2009;150: 2518-2525.
28. Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18: 950-955.
29. Knop FK. Resolution of type 2 diabetes following gastric bypass surgery: Involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia. 2009;52: 2270-2276.
30. Fetner R, McGinty J, Russell C, et al. Incretins, diabetes, and bariatric surgery: A review. Surg Obes Relat Dis. 2005;1: 589-597; discussion 597-598.
31. Geloneze B, Geloneze SR, Chaim E, et al.Metabolic surgery for non-obese type 2 diabetes: Incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg. 2012;256: 72-78.
32. Goldfine AB, Shoelson SE, Aguirre V. Expansion and contraction: Treating diabetes with bariatric surgery. Nat Med. 2009;15: 616-617.
33. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: A totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14: 275-278.
34. Cohen R, le Roux CW, Papamargaritis D, et al. Role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes. Diabet Med. 2013;30: 1482-1486. doi: 10.1111/dme.12268.
35. Athreya S, Moss J, Urquhart G, et al. Colorectal stenting for colonic obstruction: The indications, complications, effectiveness and outcome-5 year review. Eur J Radiol. 2006;60: 91-94.
36. Cohen RV, Neto MG, Correa JL, et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab. 2013;98: E279-E282.
37. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci. 2001;101: 671-679.
38. Piya MK, Tahrani AA, Barnett AH. Emerging treatment options for type 2 diabetes [published online ahead of printAugust 4, 2010]. Br J Clin Pharmacol. doi: 10.1111/j.1365-2125.2010.03711.x.